Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SYQUEST -- Ignore unavailable to you. Want to Upgrade?

To: Ralph Bergmann who wrote (5884)	3/16/1998 10:14:00 AM
From: FuzzFace	Read Replies (1) \| Respond to of 7685

SparQ sales hurting IOM? Not likely. SYQT is still just a cleaner fish hanging around the jaws of a shark. Real reasons are (in no particular order): 1) IOM's $100MM ad campaign - this Q's installment $20MM 2) Seasonal slowdown - Xmas is over kids 3) High prices (now will they lower them?) 4) Too many waiting for HiFd and other new tech, but not SparQ SparQ is crap. Don't bank on it saving SYQT.

To: Ralph Bergmann who wrote (5884)	3/16/1998 11:01:00 AM
From: LukeH	Respond to of 7685

I have spoken in great detail with someone who has just returned from Penang and spoken with middle management. The are on track for 200k SparQs and 1m cartridges this qtr in production, ramping up in Penang to 500k SparQs and 3m cartridges in the December qtr. Orders are on 6 week backlong at present. There are no substantial production issues remaining. Expect revenues in the mid $40m to $50m this qtr, ramping to $75m in the June qtr. With that kind of ramp, despite dilution, this stock is going up. Remember that it is inappropriate to consider the full dilution unless you also consider the company to hold the $200m in cash that would be injected upon the exercise of existing warrants. Product has been well-received by the marketplace and the critics; now that production issues are dissipating the stock will have a nice run over the next several months.